RANKL Signaling Sustains Primary Tumor Growth In Genetically Engineered Mouse Models Of Lung Adenocarcinoma
J. Faget, C. Contat, N. Zangger, S. Peters, E. Meylan
This study shows that blocking RANKL signaling reduces primary tumor growth in lung adenocarcinoma mouse models and suggests potential benefits for KRAS mutant lung cancer patients.
bioRxiv · May 26, 2017Cancer Biology